Sun Pharma wins over Taro with higher offer
Sun Pharmaceutical Industries has upped the buy-out price for its Israeli unit Taro Pharma by 60 per cent winning over Taro's board and ending a long battle to gain full control of the U.S. listed dru
Sun Pharmaceutical Industries has upped the buy-out price for its Israeli unit Taro Pharma by 60 per cent winning over Taro's board and ending a long battle to gain full control of the U.S. listed dru
No Articles Found
No Articles Found
No Articles Found